nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—TUBB2A—hematologic cancer	0.143	0.521	CbGaD
Paclitaxel—BCL2—hematologic cancer	0.0786	0.286	CbGaD
Paclitaxel—ABCG2—hematologic cancer	0.0375	0.136	CbGaD
Paclitaxel—ABCB1—hematologic cancer	0.0156	0.0568	CbGaD
Paclitaxel—TUBB4A—Vinorelbine—hematologic cancer	0.0122	0.0271	CbGbCtD
Paclitaxel—TUBB6—Vinorelbine—hematologic cancer	0.0122	0.0271	CbGbCtD
Paclitaxel—TUBB2A—Vinorelbine—hematologic cancer	0.0122	0.0271	CbGbCtD
Paclitaxel—TUBB3—Vinorelbine—hematologic cancer	0.0122	0.0271	CbGbCtD
Paclitaxel—TUBB2B—Vinorelbine—hematologic cancer	0.0122	0.0271	CbGbCtD
Paclitaxel—TUBB8—Vinorelbine—hematologic cancer	0.0122	0.0271	CbGbCtD
Paclitaxel—CYP1B1—Procarbazine—hematologic cancer	0.0114	0.0254	CbGbCtD
Paclitaxel—ABCC10—Daunorubicin—hematologic cancer	0.0113	0.0251	CbGbCtD
Paclitaxel—TUBB—Vinorelbine—hematologic cancer	0.0102	0.0226	CbGbCtD
Paclitaxel—TUBB1—Vinorelbine—hematologic cancer	0.0102	0.0226	CbGbCtD
Paclitaxel—TUBB4B—Vinorelbine—hematologic cancer	0.0102	0.0226	CbGbCtD
Paclitaxel—ABCC10—Cytarabine—hematologic cancer	0.00994	0.0221	CbGbCtD
Paclitaxel—TUBB2B—Vinblastine—hematologic cancer	0.0075	0.0167	CbGbCtD
Paclitaxel—TUBB8—Vinblastine—hematologic cancer	0.0075	0.0167	CbGbCtD
Paclitaxel—TUBB6—Vinblastine—hematologic cancer	0.0075	0.0167	CbGbCtD
Paclitaxel—TUBB2A—Vinblastine—hematologic cancer	0.0075	0.0167	CbGbCtD
Paclitaxel—TUBB3—Vinblastine—hematologic cancer	0.0075	0.0167	CbGbCtD
Paclitaxel—TUBB4A—Vinblastine—hematologic cancer	0.0075	0.0167	CbGbCtD
Paclitaxel—TUBB6—Vincristine—hematologic cancer	0.00737	0.0164	CbGbCtD
Paclitaxel—TUBB2A—Vincristine—hematologic cancer	0.00737	0.0164	CbGbCtD
Paclitaxel—TUBB2B—Vincristine—hematologic cancer	0.00737	0.0164	CbGbCtD
Paclitaxel—TUBB4A—Vincristine—hematologic cancer	0.00737	0.0164	CbGbCtD
Paclitaxel—TUBB3—Vincristine—hematologic cancer	0.00737	0.0164	CbGbCtD
Paclitaxel—TUBB8—Vincristine—hematologic cancer	0.00737	0.0164	CbGbCtD
Paclitaxel—TUBB—Vinblastine—hematologic cancer	0.00627	0.0139	CbGbCtD
Paclitaxel—TUBB4B—Vinblastine—hematologic cancer	0.00627	0.0139	CbGbCtD
Paclitaxel—TUBB1—Vinblastine—hematologic cancer	0.00627	0.0139	CbGbCtD
Paclitaxel—TUBB4B—Vincristine—hematologic cancer	0.00617	0.0137	CbGbCtD
Paclitaxel—TUBB1—Vincristine—hematologic cancer	0.00617	0.0137	CbGbCtD
Paclitaxel—TUBB—Vincristine—hematologic cancer	0.00617	0.0137	CbGbCtD
Paclitaxel—ABCC1—Idarubicin—hematologic cancer	0.00615	0.0137	CbGbCtD
Paclitaxel—CYP1B1—Daunorubicin—hematologic cancer	0.00613	0.0136	CbGbCtD
Paclitaxel—ABCB11—Daunorubicin—hematologic cancer	0.00613	0.0136	CbGbCtD
Paclitaxel—ABCC10—Gemcitabine—hematologic cancer	0.00605	0.0134	CbGbCtD
Paclitaxel—ABCG2—Clofarabine—hematologic cancer	0.00497	0.011	CbGbCtD
Paclitaxel—ABCC10—Vincristine—hematologic cancer	0.00471	0.0105	CbGbCtD
Paclitaxel—ABCC1—Daunorubicin—hematologic cancer	0.00435	0.00967	CbGbCtD
Paclitaxel—ABCC10—Etoposide—hematologic cancer	0.00432	0.0096	CbGbCtD
Paclitaxel—CYP1B1—Dasatinib—hematologic cancer	0.00377	0.00838	CbGbCtD
Paclitaxel—CYP1B1—Mitoxantrone—hematologic cancer	0.00372	0.00827	CbGbCtD
Paclitaxel—ABCC2—Daunorubicin—hematologic cancer	0.00322	0.00716	CbGbCtD
Paclitaxel—ABCC10—Doxorubicin—hematologic cancer	0.00295	0.00655	CbGbCtD
Paclitaxel—ABCG2—Daunorubicin—hematologic cancer	0.00291	0.00647	CbGbCtD
Paclitaxel—ABCC10—Methotrexate—hematologic cancer	0.00285	0.00634	CbGbCtD
Paclitaxel—CYP19A1—ovarian follicle—hematologic cancer	0.00285	0.0741	CbGeAlD
Paclitaxel—CYP19A1—Betamethasone—hematologic cancer	0.00269	0.00598	CbGbCtD
Paclitaxel—ABCC1—Mitoxantrone—hematologic cancer	0.00264	0.00588	CbGbCtD
Paclitaxel—ABCB11—Vinblastine—hematologic cancer	0.00261	0.00579	CbGbCtD
Paclitaxel—ABCB11—Vincristine—hematologic cancer	0.00256	0.00569	CbGbCtD
Paclitaxel—ABCG2—Teniposide—hematologic cancer	0.00253	0.00562	CbGbCtD
Paclitaxel—ABCG2—Cladribine—hematologic cancer	0.00243	0.00539	CbGbCtD
Paclitaxel—ABCG2—Imatinib—hematologic cancer	0.00223	0.00496	CbGbCtD
Paclitaxel—ABCC1—Epirubicin—hematologic cancer	0.00214	0.00476	CbGbCtD
Paclitaxel—ABCC1—Irinotecan—hematologic cancer	0.00208	0.00463	CbGbCtD
Paclitaxel—ABCG2—Nilotinib—hematologic cancer	0.00203	0.00451	CbGbCtD
Paclitaxel—ABCB11—Dexamethasone—hematologic cancer	0.00193	0.00429	CbGbCtD
Paclitaxel—CYP1B1—Dexamethasone—hematologic cancer	0.00193	0.00429	CbGbCtD
Paclitaxel—ABCC1—Vinblastine—hematologic cancer	0.00185	0.00411	CbGbCtD
Paclitaxel—CYP2C9—Bexarotene—hematologic cancer	0.00185	0.0041	CbGbCtD
Paclitaxel—ABCC1—Vincristine—hematologic cancer	0.00182	0.00404	CbGbCtD
Paclitaxel—ABCG2—Dasatinib—hematologic cancer	0.00179	0.00398	CbGbCtD
Paclitaxel—ABCB1—Lenalidomide—hematologic cancer	0.00179	0.00398	CbGbCtD
Paclitaxel—ABCG2—Mitoxantrone—hematologic cancer	0.00177	0.00393	CbGbCtD
Paclitaxel—CYP3A7—Ifosfamide—hematologic cancer	0.00172	0.00383	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.00172	0.00383	CbGbCtD
Paclitaxel—ABCC1—Etoposide—hematologic cancer	0.00167	0.00371	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.00165	0.00366	CbGbCtD
Paclitaxel—CYP3A7—Imatinib—hematologic cancer	0.00165	0.00366	CbGbCtD
Paclitaxel—CYP2C8—Bortezomib—hematologic cancer	0.00162	0.0036	CbGbCtD
Paclitaxel—CYP3A5—Daunorubicin—hematologic cancer	0.00161	0.00359	CbGbCtD
Paclitaxel—ABCB11—Doxorubicin—hematologic cancer	0.0016	0.00356	CbGbCtD
Paclitaxel—CYP1B1—Doxorubicin—hematologic cancer	0.0016	0.00356	CbGbCtD
Paclitaxel—SLCO1B3—Methotrexate—hematologic cancer	0.00159	0.00354	CbGbCtD
Paclitaxel—CYP19A1—Dexamethasone—hematologic cancer	0.00156	0.00348	CbGbCtD
Paclitaxel—ABCC2—Irinotecan—hematologic cancer	0.00154	0.00343	CbGbCtD
Paclitaxel—CYP2C9—Idarubicin—hematologic cancer	0.00153	0.0034	CbGbCtD
Paclitaxel—CYP3A5—Thalidomide—hematologic cancer	0.00147	0.00327	CbGbCtD
Paclitaxel—CYP3A5—Teniposide—hematologic cancer	0.0014	0.00312	CbGbCtD
Paclitaxel—ABCG2—Irinotecan—hematologic cancer	0.00139	0.0031	CbGbCtD
Paclitaxel—ABCC2—Vinblastine—hematologic cancer	0.00137	0.00305	CbGbCtD
Paclitaxel—ABCC2—Vincristine—hematologic cancer	0.00135	0.00299	CbGbCtD
Paclitaxel—CYP3A5—Ifosfamide—hematologic cancer	0.00129	0.00288	CbGbCtD
Paclitaxel—ABCC2—Cisplatin—hematologic cancer	0.00126	0.00279	CbGbCtD
Paclitaxel—CYP2C8—Ifosfamide—hematologic cancer	0.00124	0.00276	CbGbCtD
Paclitaxel—CYP3A5—Imatinib—hematologic cancer	0.00124	0.00275	CbGbCtD
Paclitaxel—ABCC2—Etoposide—hematologic cancer	0.00123	0.00274	CbGbCtD
Paclitaxel—ABCG2—Vincristine—hematologic cancer	0.00122	0.00271	CbGbCtD
Paclitaxel—ABCC1—Doxorubicin—hematologic cancer	0.00114	0.00253	CbGbCtD
Paclitaxel—ABCG2—Cisplatin—hematologic cancer	0.00114	0.00252	CbGbCtD
Paclitaxel—CYP2C9—Bortezomib—hematologic cancer	0.00113	0.00251	CbGbCtD
Paclitaxel—ABCG2—Etoposide—hematologic cancer	0.00112	0.00248	CbGbCtD
Paclitaxel—ABCC1—Methotrexate—hematologic cancer	0.0011	0.00245	CbGbCtD
Paclitaxel—CYP2C8—Nilotinib—hematologic cancer	0.00108	0.0024	CbGbCtD
Paclitaxel—CYP3A4—Bexarotene—hematologic cancer	0.00107	0.00239	CbGbCtD
Paclitaxel—ABCB1—Daunorubicin—hematologic cancer	0.00105	0.00233	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00103	0.00229	CbGbCtD
Paclitaxel—CYP3A7—Irinotecan—hematologic cancer	0.00103	0.00229	CbGbCtD
Paclitaxel—ABCB1—Alitretinoin—hematologic cancer	0.00103	0.00229	CbGbCtD
Paclitaxel—ABCC2—Dexamethasone—hematologic cancer	0.00101	0.00226	CbGbCtD
Paclitaxel—CYP3A4—Lomustine—hematologic cancer	0.000998	0.00222	CbGbCtD
Paclitaxel—CYP3A4—Busulfan—hematologic cancer	0.000998	0.00222	CbGbCtD
Paclitaxel—CYP3A5—Dasatinib—hematologic cancer	0.000993	0.00221	CbGbCtD
Paclitaxel—CYP2C9—Thalidomide—hematologic cancer	0.000985	0.00219	CbGbCtD
Paclitaxel—CYP2C9—Teniposide—hematologic cancer	0.00094	0.00209	CbGbCtD
Paclitaxel—ABCG2—Dexamethasone—hematologic cancer	0.000917	0.00204	CbGbCtD
Paclitaxel—CYP3A7—Vincristine—hematologic cancer	0.000899	0.002	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.000899	0.002	CbGbCtD
Paclitaxel—CYP3A4—Thiotepa—hematologic cancer	0.000889	0.00198	CbGbCtD
Paclitaxel—Cabazitaxel—TUBB2A—hematologic cancer	0.000883	0.342	CrCbGaD
Paclitaxel—CYP2C9—Ifosfamide—hematologic cancer	0.000868	0.00193	CbGbCtD
Paclitaxel—MAP4—hematopoietic system—hematologic cancer	0.000855	0.0222	CbGeAlD
Paclitaxel—TUBB3—hematopoietic system—hematologic cancer	0.000855	0.0222	CbGeAlD
Paclitaxel—ABCC2—Doxorubicin—hematologic cancer	0.000842	0.00187	CbGbCtD
Paclitaxel—TUBB1—hematopoietic system—hematologic cancer	0.000836	0.0217	CbGeAlD
Paclitaxel—CYP2C9—Imatinib—hematologic cancer	0.000829	0.00184	CbGbCtD
Paclitaxel—ABCC2—Methotrexate—hematologic cancer	0.000816	0.00181	CbGbCtD
Paclitaxel—ABCB1—Imatinib—hematologic cancer	0.000804	0.00179	CbGbCtD
Paclitaxel—BCL2—hematopoietic system—hematologic cancer	0.000777	0.0202	CbGeAlD
Paclitaxel—CYP3A5—Irinotecan—hematologic cancer	0.000772	0.00172	CbGbCtD
Paclitaxel—ABCG2—Doxorubicin—hematologic cancer	0.000761	0.00169	CbGbCtD
Paclitaxel—CYP2C9—Nilotinib—hematologic cancer	0.000753	0.00167	CbGbCtD
Paclitaxel—ABCG2—Methotrexate—hematologic cancer	0.000737	0.00164	CbGbCtD
Paclitaxel—ABCB1—Nilotinib—hematologic cancer	0.000731	0.00162	CbGbCtD
Paclitaxel—ABCB1—Vinorelbine—hematologic cancer	0.000725	0.00161	CbGbCtD
Paclitaxel—Docetaxel—TUBB2A—hematologic cancer	0.000713	0.277	CrCbGaD
Paclitaxel—CYP3A4—Methoxsalen—hematologic cancer	0.000691	0.00154	CbGbCtD
Paclitaxel—TUBB8—testis—hematologic cancer	0.000687	0.0179	CbGeAlD
Paclitaxel—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.000678	0.00151	CbGbCtD
Paclitaxel—CYP3A7—Dexamethasone—hematologic cancer	0.000678	0.00151	CbGbCtD
Paclitaxel—CYP3A5—Vincristine—hematologic cancer	0.000675	0.0015	CbGbCtD
Paclitaxel—MAP2—hematopoietic system—hematologic cancer	0.000673	0.0175	CbGeAlD
Paclitaxel—CYP3A4—Bortezomib—hematologic cancer	0.000658	0.00146	CbGbCtD
Paclitaxel—MAP4—gonad—hematologic cancer	0.00065	0.0169	CbGeAlD
Paclitaxel—ABCB1—Dasatinib—hematologic cancer	0.000646	0.00144	CbGbCtD
Paclitaxel—ABCB1—Mitoxantrone—hematologic cancer	0.000638	0.00142	CbGbCtD
Paclitaxel—CYP3A4—Daunorubicin—hematologic cancer	0.000629	0.0014	CbGbCtD
Paclitaxel—CYP3A5—Etoposide—hematologic cancer	0.000618	0.00137	CbGbCtD
Paclitaxel—MAPT—testis—hematologic cancer	0.000596	0.0155	CbGeAlD
Paclitaxel—CYP2C8—Etoposide—hematologic cancer	0.000594	0.00132	CbGbCtD
Paclitaxel—BCL2—gonad—hematologic cancer	0.000591	0.0154	CbGeAlD
Paclitaxel—ABCB1—Betamethasone—hematologic cancer	0.000569	0.00126	CbGbCtD
Paclitaxel—TUBB3—blood—hematologic cancer	0.000567	0.0147	CbGeAlD
Paclitaxel—MAP4—blood—hematologic cancer	0.000567	0.0147	CbGeAlD
Paclitaxel—ABCB1—Gemcitabine—hematologic cancer	0.000564	0.00125	CbGbCtD
Paclitaxel—ABCB1—Prednisolone—hematologic cancer	0.000561	0.00125	CbGbCtD
Paclitaxel—CYP3A4—Cytarabine—hematologic cancer	0.000555	0.00123	CbGbCtD
Paclitaxel—TUBB1—blood—hematologic cancer	0.000554	0.0144	CbGeAlD
Paclitaxel—CYP3A4—Teniposide—hematologic cancer	0.000547	0.00122	CbGbCtD
Paclitaxel—TUBB1—bone marrow—hematologic cancer	0.000536	0.0139	CbGeAlD
Paclitaxel—ABCB1—Prednisone—hematologic cancer	0.00053	0.00118	CbGbCtD
Paclitaxel—TUBB4A—hematopoietic system—hematologic cancer	0.00052	0.0135	CbGeAlD
Paclitaxel—BCL2—blood—hematologic cancer	0.000515	0.0134	CbGeAlD
Paclitaxel—MAP2—gonad—hematologic cancer	0.000512	0.0133	CbGeAlD
Paclitaxel—CYP3A5—Dexamethasone—hematologic cancer	0.000508	0.00113	CbGbCtD
Paclitaxel—CYP3A4—Ifosfamide—hematologic cancer	0.000504	0.00112	CbGbCtD
Paclitaxel—ABCB1—Irinotecan—hematologic cancer	0.000502	0.00112	CbGbCtD
Paclitaxel—BCL2—bone marrow—hematologic cancer	0.000498	0.013	CbGeAlD
Paclitaxel—MAP4—lung—hematologic cancer	0.000497	0.0129	CbGeAlD
Paclitaxel—TUBB3—lung—hematologic cancer	0.000497	0.0129	CbGeAlD
Paclitaxel—CYP2C8—Dexamethasone—hematologic cancer	0.000489	0.00109	CbGbCtD
Paclitaxel—CYP3A4—Imatinib—hematologic cancer	0.000482	0.00107	CbGbCtD
Paclitaxel—TUBB2A—hematopoietic system—hematologic cancer	0.000474	0.0123	CbGeAlD
Paclitaxel—TUBB3—testis—hematologic cancer	0.000469	0.0122	CbGeAlD
Paclitaxel—MAP4—testis—hematologic cancer	0.000469	0.0122	CbGeAlD
Paclitaxel—TUBB6—hematopoietic system—hematologic cancer	0.000467	0.0121	CbGeAlD
Paclitaxel—TUBB1—testis—hematologic cancer	0.000458	0.0119	CbGeAlD
Paclitaxel—CYP3A4—Ruxolitinib—hematologic cancer	0.000454	0.00101	CbGbCtD
Paclitaxel—BCL2—lung—hematologic cancer	0.000452	0.0117	CbGeAlD
Paclitaxel—ABCB1—Vinblastine—hematologic cancer	0.000447	0.000993	CbGbCtD
Paclitaxel—MAP2—blood—hematologic cancer	0.000446	0.0116	CbGeAlD
Paclitaxel—ABCB1—Vincristine—hematologic cancer	0.000439	0.000976	CbGbCtD
Paclitaxel—CYP3A4—Nilotinib—hematologic cancer	0.000438	0.000973	CbGbCtD
Paclitaxel—SLCO1B3—lung—hematologic cancer	0.000435	0.0113	CbGeAlD
Paclitaxel—CYP3A4—Vinorelbine—hematologic cancer	0.000434	0.000965	CbGbCtD
Paclitaxel—MAPT—lymph node—hematologic cancer	0.000432	0.0112	CbGeAlD
Paclitaxel—BCL2—testis—hematologic cancer	0.000426	0.0111	CbGeAlD
Paclitaxel—CYP2C9—Cisplatin—hematologic cancer	0.000422	0.000938	CbGbCtD
Paclitaxel—ABCB1—Cisplatin—hematologic cancer	0.00041	0.00091	CbGbCtD
Paclitaxel—ABCC10—hematopoietic system—hematologic cancer	0.000409	0.0106	CbGeAlD
Paclitaxel—TUBB4B—hematopoietic system—hematologic cancer	0.000406	0.0106	CbGeAlD
Paclitaxel—ABCB1—Etoposide—hematologic cancer	0.000402	0.000894	CbGbCtD
Paclitaxel—CYP3A4—Triamcinolone—hematologic cancer	0.000397	0.000883	CbGbCtD
Paclitaxel—TUBB4A—gonad—hematologic cancer	0.000396	0.0103	CbGeAlD
Paclitaxel—MAP2—lung—hematologic cancer	0.000391	0.0102	CbGeAlD
Paclitaxel—Docetaxel—BCL2—hematologic cancer	0.000391	0.151	CrCbGaD
Paclitaxel—CYP3A4—Dasatinib—hematologic cancer	0.000387	0.00086	CbGbCtD
Paclitaxel—TUBB2B—gonad—hematologic cancer	0.000382	0.00994	CbGeAlD
Paclitaxel—CYP3A4—Mitoxantrone—hematologic cancer	0.000382	0.00085	CbGbCtD
Paclitaxel—MAP2—testis—hematologic cancer	0.000369	0.00959	CbGeAlD
Paclitaxel—TUBB6—gonad—hematologic cancer	0.000355	0.00923	CbGeAlD
Paclitaxel—ABCB11—testis—hematologic cancer	0.000354	0.0092	CbGeAlD
Paclitaxel—TUBB4A—blood—hematologic cancer	0.000345	0.00896	CbGeAlD
Paclitaxel—CYP19A1—hematopoietic system—hematologic cancer	0.000344	0.00894	CbGeAlD
Paclitaxel—CYP2C9—Dexamethasone—hematologic cancer	0.000341	0.000758	CbGbCtD
Paclitaxel—CYP3A4—Betamethasone—hematologic cancer	0.000341	0.000757	CbGbCtD
Paclitaxel—MAP4—lymph node—hematologic cancer	0.00034	0.00883	CbGeAlD
Paclitaxel—CYP3A4—Prednisolone—hematologic cancer	0.000336	0.000747	CbGbCtD
Paclitaxel—ABCB1—Dexamethasone—hematologic cancer	0.000331	0.000735	CbGbCtD
Paclitaxel—CYP1B1—hematopoietic system—hematologic cancer	0.000322	0.00836	CbGeAlD
Paclitaxel—CYP3A4—Prednisone—hematologic cancer	0.000317	0.000706	CbGbCtD
Paclitaxel—TUBB—blood—hematologic cancer	0.000315	0.0082	CbGeAlD
Paclitaxel—TUBB2A—blood—hematologic cancer	0.000314	0.00815	CbGeAlD
Paclitaxel—ABCC10—gonad—hematologic cancer	0.000311	0.00808	CbGeAlD
Paclitaxel—TUBB6—blood—hematologic cancer	0.000309	0.00804	CbGeAlD
Paclitaxel—BCL2—lymph node—hematologic cancer	0.000309	0.00803	CbGeAlD
Paclitaxel—TUBB4B—gonad—hematologic cancer	0.000309	0.00802	CbGeAlD
Paclitaxel—TUBB—bone marrow—hematologic cancer	0.000305	0.00793	CbGeAlD
Paclitaxel—TUBB2A—bone marrow—hematologic cancer	0.000304	0.00789	CbGeAlD
Paclitaxel—TUBB4A—lung—hematologic cancer	0.000302	0.00786	CbGeAlD
Paclitaxel—CYP3A4—Irinotecan—hematologic cancer	0.000301	0.000669	CbGbCtD
Paclitaxel—TUBB6—bone marrow—hematologic cancer	0.000299	0.00778	CbGeAlD
Paclitaxel—TUBB2B—lung—hematologic cancer	0.000292	0.00759	CbGeAlD
Paclitaxel—TUBB4A—testis—hematologic cancer	0.000285	0.00741	CbGeAlD
Paclitaxel—TUBB—lung—hematologic cancer	0.000276	0.00719	CbGeAlD
Paclitaxel—TUBB2B—testis—hematologic cancer	0.000276	0.00717	CbGeAlD
Paclitaxel—TUBB2A—lung—hematologic cancer	0.000275	0.00715	CbGeAlD
Paclitaxel—ABCB1—Doxorubicin—hematologic cancer	0.000274	0.00061	CbGbCtD
Paclitaxel—TUBB6—lung—hematologic cancer	0.000271	0.00705	CbGeAlD
Paclitaxel—ABCC10—blood—hematologic cancer	0.000271	0.00704	CbGeAlD
Paclitaxel—TUBB4B—blood—hematologic cancer	0.000269	0.00699	CbGeAlD
Paclitaxel—CYP3A4—Vinblastine—hematologic cancer	0.000268	0.000595	CbGbCtD
Paclitaxel—MAP2—lymph node—hematologic cancer	0.000268	0.00695	CbGeAlD
Paclitaxel—ABCB1—Methotrexate—hematologic cancer	0.000266	0.000591	CbGbCtD
Paclitaxel—CYP3A4—Vincristine—hematologic cancer	0.000263	0.000585	CbGbCtD
Paclitaxel—ABCC10—bone marrow—hematologic cancer	0.000262	0.00681	CbGeAlD
Paclitaxel—CYP19A1—gonad—hematologic cancer	0.000262	0.0068	CbGeAlD
Paclitaxel—TUBB—testis—hematologic cancer	0.000261	0.00678	CbGeAlD
Paclitaxel—TUBB4B—bone marrow—hematologic cancer	0.00026	0.00676	CbGeAlD
Paclitaxel—TUBB2A—testis—hematologic cancer	0.000259	0.00674	CbGeAlD
Paclitaxel—TUBB6—testis—hematologic cancer	0.000256	0.00665	CbGeAlD
Paclitaxel—BCL2—Isotretinoin—Alitretinoin—hematologic cancer	0.000248	0.138	CbGdCrCtD
Paclitaxel—BCL2—Tretinoin—Alitretinoin—hematologic cancer	0.000248	0.138	CbGdCrCtD
Paclitaxel—CYP2C8—hematopoietic system—hematologic cancer	0.000246	0.0064	CbGeAlD
Paclitaxel—CYP1B1—gonad—hematologic cancer	0.000244	0.00635	CbGeAlD
Paclitaxel—CYP3A4—Etoposide—hematologic cancer	0.000241	0.000536	CbGbCtD
Paclitaxel—ABCC10—lung—hematologic cancer	0.000237	0.00617	CbGeAlD
Paclitaxel—TUBB4B—lung—hematologic cancer	0.000236	0.00613	CbGeAlD
Paclitaxel—Cabazitaxel—ABCG2—hematologic cancer	0.000231	0.0896	CrCbGaD
Paclitaxel—CYP19A1—blood—hematologic cancer	0.000228	0.00592	CbGeAlD
Paclitaxel—ABCC10—testis—hematologic cancer	0.000224	0.00582	CbGeAlD
Paclitaxel—TUBB4B—testis—hematologic cancer	0.000222	0.00578	CbGeAlD
Paclitaxel—CYP3A5—hematopoietic system—hematologic cancer	0.000222	0.00578	CbGeAlD
Paclitaxel—CYP2C9—hematopoietic system—hematologic cancer	0.000219	0.00569	CbGeAlD
Paclitaxel—ABCC2—blood—hematologic cancer	0.000218	0.00565	CbGeAlD
Paclitaxel—CYP1B1—blood—hematologic cancer	0.000213	0.00554	CbGeAlD
Paclitaxel—TUBB4A—lymph node—hematologic cancer	0.000207	0.00537	CbGeAlD
Paclitaxel—TUBB2B—lymph node—hematologic cancer	0.0002	0.00519	CbGeAlD
Paclitaxel—CYP3A4—Dexamethasone—hematologic cancer	0.000198	0.000441	CbGbCtD
Paclitaxel—ABCC1—blood—hematologic cancer	0.000192	0.00498	CbGeAlD
Paclitaxel—TUBB—lymph node—hematologic cancer	0.000189	0.00492	CbGeAlD
Paclitaxel—CYP19A1—testis—hematologic cancer	0.000188	0.0049	CbGeAlD
Paclitaxel—TUBB2A—lymph node—hematologic cancer	0.000188	0.00489	CbGeAlD
Paclitaxel—CYP1B1—lung—hematologic cancer	0.000187	0.00485	CbGeAlD
Paclitaxel—Docetaxel—ABCG2—hematologic cancer	0.000187	0.0724	CrCbGaD
Paclitaxel—TUBB6—lymph node—hematologic cancer	0.000186	0.00482	CbGeAlD
Paclitaxel—ABCC2—testis—hematologic cancer	0.00018	0.00468	CbGeAlD
Paclitaxel—CYP1B1—testis—hematologic cancer	0.000176	0.00458	CbGeAlD
Paclitaxel—ABCC1—lung—hematologic cancer	0.000168	0.00437	CbGeAlD
Paclitaxel—CYP3A4—hematopoietic system—hematologic cancer	0.000167	0.00434	CbGeAlD
Paclitaxel—CYP3A4—Doxorubicin—hematologic cancer	0.000164	0.000365	CbGbCtD
Paclitaxel—TUBB—Menadione—Thalidomide—hematologic cancer	0.000164	0.0916	CbGdCrCtD
Paclitaxel—CYP2C8—blood—hematologic cancer	0.000163	0.00424	CbGeAlD
Paclitaxel—ABCC10—lymph node—hematologic cancer	0.000162	0.00422	CbGeAlD
Paclitaxel—TUBB4B—lymph node—hematologic cancer	0.000161	0.00419	CbGeAlD
Paclitaxel—ABCG2—blood—hematologic cancer	0.000159	0.00412	CbGeAlD
Paclitaxel—ABCC1—testis—hematologic cancer	0.000158	0.00412	CbGeAlD
Paclitaxel—ABCG2—bone marrow—hematologic cancer	0.000153	0.00399	CbGeAlD
Paclitaxel—CYP3A5—blood—hematologic cancer	0.000147	0.00383	CbGeAlD
Paclitaxel—CYP2C9—blood—hematologic cancer	0.000145	0.00377	CbGeAlD
Paclitaxel—ABCG2—lung—hematologic cancer	0.000139	0.00361	CbGeAlD
Paclitaxel—CYP19A1—lymph node—hematologic cancer	0.000137	0.00355	CbGeAlD
Paclitaxel—CYP2C8—testis—hematologic cancer	0.000135	0.00351	CbGeAlD
Paclitaxel—ABCG2—testis—hematologic cancer	0.000131	0.00341	CbGeAlD
Paclitaxel—ABCC2—lymph node—hematologic cancer	0.00013	0.00339	CbGeAlD
Paclitaxel—CYP3A5—lung—hematologic cancer	0.000129	0.00336	CbGeAlD
Paclitaxel—TUBB6—Vitamin A—Alitretinoin—hematologic cancer	0.000128	0.0717	CbGdCrCtD
Paclitaxel—CYP1B1—lymph node—hematologic cancer	0.000128	0.00332	CbGeAlD
Paclitaxel—ABCB1—hematopoietic system—hematologic cancer	0.000118	0.00307	CbGeAlD
Paclitaxel—ABCC1—lymph node—hematologic cancer	0.000115	0.00299	CbGeAlD
Paclitaxel—CYP3A4—blood—hematologic cancer	0.000111	0.00287	CbGeAlD
Paclitaxel—TUBB6—Zalcitabine—Gemcitabine—hematologic cancer	0.000102	0.0569	CbGdCrCtD
Paclitaxel—TUBB6—Zalcitabine—Cytarabine—hematologic cancer	0.000102	0.0569	CbGdCrCtD
Paclitaxel—Cabazitaxel—ABCB1—hematologic cancer	9.62e-05	0.0373	CrCbGaD
Paclitaxel—ABCG2—lymph node—hematologic cancer	9.51e-05	0.00247	CbGeAlD
Paclitaxel—TUBB6—Tretinoin—Alitretinoin—hematologic cancer	8.98e-05	0.0501	CbGdCrCtD
Paclitaxel—TUBB6—Isotretinoin—Alitretinoin—hematologic cancer	8.98e-05	0.0501	CbGdCrCtD
Paclitaxel—ABCB1—gonad—hematologic cancer	8.98e-05	0.00233	CbGeAlD
Paclitaxel—TUBB—Azacitidine—Pentostatin—hematologic cancer	8.41e-05	0.0469	CbGdCrCtD
Paclitaxel—ABCB1—blood—hematologic cancer	7.82e-05	0.00203	CbGeAlD
Paclitaxel—Docetaxel—ABCB1—hematologic cancer	7.77e-05	0.0301	CrCbGaD
Paclitaxel—ABCB1—bone marrow—hematologic cancer	7.57e-05	0.00197	CbGeAlD
Paclitaxel—TUBB—Azacitidine—Clofarabine—hematologic cancer	7.5e-05	0.0418	CbGdCrCtD
Paclitaxel—TUBB—Azacitidine—Nelarabine—hematologic cancer	7.05e-05	0.0393	CbGdCrCtD
Paclitaxel—ABCB1—lung—hematologic cancer	6.86e-05	0.00178	CbGeAlD
Paclitaxel—ABCB1—testis—hematologic cancer	6.47e-05	0.00168	CbGeAlD
Paclitaxel—TUBB—Azacitidine—Fludarabine—hematologic cancer	5.5e-05	0.0307	CbGdCrCtD
Paclitaxel—TUBB—Azacitidine—Gemcitabine—hematologic cancer	5.2e-05	0.029	CbGdCrCtD
Paclitaxel—TUBB—Azacitidine—Cytarabine—hematologic cancer	5.2e-05	0.029	CbGdCrCtD
Paclitaxel—TUBB—Azacitidine—Cladribine—hematologic cancer	5.06e-05	0.0282	CbGdCrCtD
Paclitaxel—ABCB1—lymph node—hematologic cancer	4.69e-05	0.00122	CbGeAlD
Paclitaxel—TUBB6—Azacitidine—Pentostatin—hematologic cancer	3.47e-05	0.0194	CbGdCrCtD
Paclitaxel—TUBB6—Azacitidine—Clofarabine—hematologic cancer	3.1e-05	0.0173	CbGdCrCtD
Paclitaxel—TUBB6—Azacitidine—Nelarabine—hematologic cancer	2.91e-05	0.0162	CbGdCrCtD
Paclitaxel—TUBB6—Azacitidine—Fludarabine—hematologic cancer	2.27e-05	0.0127	CbGdCrCtD
Paclitaxel—TUBB6—Azacitidine—Cytarabine—hematologic cancer	2.15e-05	0.012	CbGdCrCtD
Paclitaxel—TUBB6—Azacitidine—Gemcitabine—hematologic cancer	2.15e-05	0.012	CbGdCrCtD
Paclitaxel—TUBB6—Azacitidine—Cladribine—hematologic cancer	2.09e-05	0.0117	CbGdCrCtD
Paclitaxel—Flatulence—Epirubicin—hematologic cancer	4.47e-06	2.98e-05	CcSEcCtD
Paclitaxel—Tension—Epirubicin—hematologic cancer	4.45e-06	2.97e-05	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Dexamethasone—hematologic cancer	4.45e-06	2.97e-05	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Betamethasone—hematologic cancer	4.45e-06	2.97e-05	CcSEcCtD
Paclitaxel—Dysgeusia—Epirubicin—hematologic cancer	4.45e-06	2.97e-05	CcSEcCtD
Paclitaxel—Hypersensitivity—Triamcinolone—hematologic cancer	4.42e-06	2.95e-05	CcSEcCtD
Paclitaxel—Nervousness—Epirubicin—hematologic cancer	4.41e-06	2.94e-05	CcSEcCtD
Paclitaxel—Back pain—Epirubicin—hematologic cancer	4.39e-06	2.93e-05	CcSEcCtD
Paclitaxel—Angiopathy—Doxorubicin—hematologic cancer	4.38e-06	2.92e-05	CcSEcCtD
Paclitaxel—Malaise—Methotrexate—hematologic cancer	4.37e-06	2.92e-05	CcSEcCtD
Paclitaxel—Dizziness—Etoposide—hematologic cancer	4.37e-06	2.92e-05	CcSEcCtD
Paclitaxel—Muscle spasms—Epirubicin—hematologic cancer	4.36e-06	2.91e-05	CcSEcCtD
Paclitaxel—Immune system disorder—Doxorubicin—hematologic cancer	4.36e-06	2.91e-05	CcSEcCtD
Paclitaxel—Vertigo—Methotrexate—hematologic cancer	4.36e-06	2.91e-05	CcSEcCtD
Paclitaxel—Mediastinal disorder—Doxorubicin—hematologic cancer	4.35e-06	2.9e-05	CcSEcCtD
Paclitaxel—Leukopenia—Methotrexate—hematologic cancer	4.34e-06	2.9e-05	CcSEcCtD
Paclitaxel—Chills—Doxorubicin—hematologic cancer	4.33e-06	2.89e-05	CcSEcCtD
Paclitaxel—Urticaria—Betamethasone—hematologic cancer	4.32e-06	2.88e-05	CcSEcCtD
Paclitaxel—Urticaria—Dexamethasone—hematologic cancer	4.32e-06	2.88e-05	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Prednisone—hematologic cancer	4.32e-06	2.88e-05	CcSEcCtD
Paclitaxel—Dizziness—Prednisolone—hematologic cancer	4.31e-06	2.88e-05	CcSEcCtD
Paclitaxel—Arrhythmia—Doxorubicin—hematologic cancer	4.31e-06	2.88e-05	CcSEcCtD
Paclitaxel—Asthenia—Triamcinolone—hematologic cancer	4.3e-06	2.87e-05	CcSEcCtD
Paclitaxel—Body temperature increased—Betamethasone—hematologic cancer	4.3e-06	2.87e-05	CcSEcCtD
Paclitaxel—Abdominal pain—Betamethasone—hematologic cancer	4.3e-06	2.87e-05	CcSEcCtD
Paclitaxel—Abdominal pain—Dexamethasone—hematologic cancer	4.3e-06	2.87e-05	CcSEcCtD
Paclitaxel—Body temperature increased—Dexamethasone—hematologic cancer	4.3e-06	2.87e-05	CcSEcCtD
Paclitaxel—Nausea—Cisplatin—hematologic cancer	4.29e-06	2.86e-05	CcSEcCtD
Paclitaxel—Insomnia—Prednisone—hematologic cancer	4.28e-06	2.86e-05	CcSEcCtD
Paclitaxel—Vision blurred—Epirubicin—hematologic cancer	4.28e-06	2.85e-05	CcSEcCtD
Paclitaxel—Alopecia—Doxorubicin—hematologic cancer	4.26e-06	2.84e-05	CcSEcCtD
Paclitaxel—Paraesthesia—Prednisone—hematologic cancer	4.25e-06	2.84e-05	CcSEcCtD
Paclitaxel—Pruritus—Triamcinolone—hematologic cancer	4.24e-06	2.83e-05	CcSEcCtD
Paclitaxel—Cough—Methotrexate—hematologic cancer	4.23e-06	2.82e-05	CcSEcCtD
Paclitaxel—Mental disorder—Doxorubicin—hematologic cancer	4.23e-06	2.82e-05	CcSEcCtD
Paclitaxel—Ill-defined disorder—Epirubicin—hematologic cancer	4.21e-06	2.81e-05	CcSEcCtD
Paclitaxel—Convulsion—Methotrexate—hematologic cancer	4.2e-06	2.8e-05	CcSEcCtD
Paclitaxel—Vomiting—Etoposide—hematologic cancer	4.2e-06	2.8e-05	CcSEcCtD
Paclitaxel—Erythema—Doxorubicin—hematologic cancer	4.2e-06	2.8e-05	CcSEcCtD
Paclitaxel—Malnutrition—Doxorubicin—hematologic cancer	4.2e-06	2.8e-05	CcSEcCtD
Paclitaxel—Anaemia—Epirubicin—hematologic cancer	4.2e-06	2.8e-05	CcSEcCtD
Paclitaxel—Agitation—Epirubicin—hematologic cancer	4.17e-06	2.78e-05	CcSEcCtD
Paclitaxel—Dyspepsia—Prednisone—hematologic cancer	4.17e-06	2.78e-05	CcSEcCtD
Paclitaxel—Rash—Etoposide—hematologic cancer	4.17e-06	2.78e-05	CcSEcCtD
Paclitaxel—Dermatitis—Etoposide—hematologic cancer	4.16e-06	2.78e-05	CcSEcCtD
Paclitaxel—Headache—Etoposide—hematologic cancer	4.14e-06	2.76e-05	CcSEcCtD
Paclitaxel—Flatulence—Doxorubicin—hematologic cancer	4.14e-06	2.76e-05	CcSEcCtD
Paclitaxel—Chest pain—Methotrexate—hematologic cancer	4.13e-06	2.76e-05	CcSEcCtD
Paclitaxel—Myalgia—Methotrexate—hematologic cancer	4.13e-06	2.76e-05	CcSEcCtD
Paclitaxel—Arthralgia—Methotrexate—hematologic cancer	4.13e-06	2.76e-05	CcSEcCtD
Paclitaxel—Tension—Doxorubicin—hematologic cancer	4.12e-06	2.75e-05	CcSEcCtD
Paclitaxel—Decreased appetite—Prednisone—hematologic cancer	4.12e-06	2.75e-05	CcSEcCtD
Paclitaxel—Dysgeusia—Doxorubicin—hematologic cancer	4.11e-06	2.74e-05	CcSEcCtD
Paclitaxel—Rash—Prednisolone—hematologic cancer	4.11e-06	2.74e-05	CcSEcCtD
Paclitaxel—Dermatitis—Prednisolone—hematologic cancer	4.11e-06	2.74e-05	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	4.1e-06	2.74e-05	CcSEcCtD
Paclitaxel—Malaise—Epirubicin—hematologic cancer	4.09e-06	2.73e-05	CcSEcCtD
Paclitaxel—Fatigue—Prednisone—hematologic cancer	4.08e-06	2.72e-05	CcSEcCtD
Paclitaxel—Headache—Prednisolone—hematologic cancer	4.08e-06	2.72e-05	CcSEcCtD
Paclitaxel—Discomfort—Methotrexate—hematologic cancer	4.08e-06	2.72e-05	CcSEcCtD
Paclitaxel—Nervousness—Doxorubicin—hematologic cancer	4.08e-06	2.72e-05	CcSEcCtD
Paclitaxel—Vertigo—Epirubicin—hematologic cancer	4.08e-06	2.72e-05	CcSEcCtD
Paclitaxel—Syncope—Epirubicin—hematologic cancer	4.07e-06	2.72e-05	CcSEcCtD
Paclitaxel—Leukopenia—Epirubicin—hematologic cancer	4.06e-06	2.71e-05	CcSEcCtD
Paclitaxel—Back pain—Doxorubicin—hematologic cancer	4.06e-06	2.71e-05	CcSEcCtD
Paclitaxel—Constipation—Prednisone—hematologic cancer	4.05e-06	2.7e-05	CcSEcCtD
Paclitaxel—Muscle spasms—Doxorubicin—hematologic cancer	4.04e-06	2.69e-05	CcSEcCtD
Paclitaxel—Palpitations—Epirubicin—hematologic cancer	4.01e-06	2.68e-05	CcSEcCtD
Paclitaxel—Confusional state—Methotrexate—hematologic cancer	3.99e-06	2.66e-05	CcSEcCtD
Paclitaxel—Loss of consciousness—Epirubicin—hematologic cancer	3.99e-06	2.66e-05	CcSEcCtD
Paclitaxel—Dizziness—Triamcinolone—hematologic cancer	3.96e-06	2.64e-05	CcSEcCtD
Paclitaxel—Cough—Epirubicin—hematologic cancer	3.96e-06	2.64e-05	CcSEcCtD
Paclitaxel—Anaphylactic shock—Methotrexate—hematologic cancer	3.96e-06	2.64e-05	CcSEcCtD
Paclitaxel—Vision blurred—Doxorubicin—hematologic cancer	3.96e-06	2.64e-05	CcSEcCtD
Paclitaxel—Convulsion—Epirubicin—hematologic cancer	3.93e-06	2.62e-05	CcSEcCtD
Paclitaxel—Infection—Methotrexate—hematologic cancer	3.93e-06	2.62e-05	CcSEcCtD
Paclitaxel—Nausea—Etoposide—hematologic cancer	3.93e-06	2.62e-05	CcSEcCtD
Paclitaxel—Hypertension—Epirubicin—hematologic cancer	3.92e-06	2.61e-05	CcSEcCtD
Paclitaxel—Feeling abnormal—Prednisone—hematologic cancer	3.9e-06	2.6e-05	CcSEcCtD
Paclitaxel—Asthenia—Betamethasone—hematologic cancer	3.9e-06	2.6e-05	CcSEcCtD
Paclitaxel—Asthenia—Dexamethasone—hematologic cancer	3.9e-06	2.6e-05	CcSEcCtD
Paclitaxel—Ill-defined disorder—Doxorubicin—hematologic cancer	3.9e-06	2.6e-05	CcSEcCtD
Paclitaxel—Nervous system disorder—Methotrexate—hematologic cancer	3.88e-06	2.59e-05	CcSEcCtD
Paclitaxel—Anaemia—Doxorubicin—hematologic cancer	3.88e-06	2.59e-05	CcSEcCtD
Paclitaxel—Thrombocytopenia—Methotrexate—hematologic cancer	3.88e-06	2.59e-05	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Prednisone—hematologic cancer	3.87e-06	2.58e-05	CcSEcCtD
Paclitaxel—Nausea—Prednisolone—hematologic cancer	3.87e-06	2.58e-05	CcSEcCtD
Paclitaxel—Chest pain—Epirubicin—hematologic cancer	3.86e-06	2.58e-05	CcSEcCtD
Paclitaxel—Arthralgia—Epirubicin—hematologic cancer	3.86e-06	2.58e-05	CcSEcCtD
Paclitaxel—Myalgia—Epirubicin—hematologic cancer	3.86e-06	2.58e-05	CcSEcCtD
Paclitaxel—Agitation—Doxorubicin—hematologic cancer	3.86e-06	2.58e-05	CcSEcCtD
Paclitaxel—Anxiety—Epirubicin—hematologic cancer	3.85e-06	2.57e-05	CcSEcCtD
Paclitaxel—Pruritus—Dexamethasone—hematologic cancer	3.85e-06	2.57e-05	CcSEcCtD
Paclitaxel—Pruritus—Betamethasone—hematologic cancer	3.85e-06	2.57e-05	CcSEcCtD
Paclitaxel—Skin disorder—Methotrexate—hematologic cancer	3.85e-06	2.57e-05	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	3.84e-06	2.56e-05	CcSEcCtD
Paclitaxel—Hyperhidrosis—Methotrexate—hematologic cancer	3.83e-06	2.55e-05	CcSEcCtD
Paclitaxel—Discomfort—Epirubicin—hematologic cancer	3.82e-06	2.55e-05	CcSEcCtD
Paclitaxel—Vomiting—Triamcinolone—hematologic cancer	3.81e-06	2.54e-05	CcSEcCtD
Paclitaxel—Malaise—Doxorubicin—hematologic cancer	3.79e-06	2.53e-05	CcSEcCtD
Paclitaxel—Rash—Triamcinolone—hematologic cancer	3.78e-06	2.52e-05	CcSEcCtD
Paclitaxel—Dry mouth—Epirubicin—hematologic cancer	3.78e-06	2.52e-05	CcSEcCtD
Paclitaxel—Dermatitis—Triamcinolone—hematologic cancer	3.78e-06	2.52e-05	CcSEcCtD
Paclitaxel—Vertigo—Doxorubicin—hematologic cancer	3.77e-06	2.52e-05	CcSEcCtD
Paclitaxel—Anorexia—Methotrexate—hematologic cancer	3.77e-06	2.52e-05	CcSEcCtD
Paclitaxel—Syncope—Doxorubicin—hematologic cancer	3.77e-06	2.51e-05	CcSEcCtD
Paclitaxel—Urticaria—Prednisone—hematologic cancer	3.76e-06	2.51e-05	CcSEcCtD
Paclitaxel—Leukopenia—Doxorubicin—hematologic cancer	3.76e-06	2.51e-05	CcSEcCtD
Paclitaxel—Headache—Triamcinolone—hematologic cancer	3.76e-06	2.51e-05	CcSEcCtD
Paclitaxel—Abdominal pain—Prednisone—hematologic cancer	3.74e-06	2.5e-05	CcSEcCtD
Paclitaxel—Body temperature increased—Prednisone—hematologic cancer	3.74e-06	2.5e-05	CcSEcCtD
Paclitaxel—Confusional state—Epirubicin—hematologic cancer	3.74e-06	2.49e-05	CcSEcCtD
Paclitaxel—Diarrhoea—Dexamethasone—hematologic cancer	3.72e-06	2.48e-05	CcSEcCtD
Paclitaxel—Diarrhoea—Betamethasone—hematologic cancer	3.72e-06	2.48e-05	CcSEcCtD
Paclitaxel—Palpitations—Doxorubicin—hematologic cancer	3.71e-06	2.48e-05	CcSEcCtD
Paclitaxel—Oedema—Epirubicin—hematologic cancer	3.7e-06	2.47e-05	CcSEcCtD
Paclitaxel—Anaphylactic shock—Epirubicin—hematologic cancer	3.7e-06	2.47e-05	CcSEcCtD
Paclitaxel—Hypotension—Methotrexate—hematologic cancer	3.7e-06	2.47e-05	CcSEcCtD
Paclitaxel—Loss of consciousness—Doxorubicin—hematologic cancer	3.69e-06	2.46e-05	CcSEcCtD
Paclitaxel—Infection—Epirubicin—hematologic cancer	3.68e-06	2.46e-05	CcSEcCtD
Paclitaxel—Cough—Doxorubicin—hematologic cancer	3.67e-06	2.45e-05	CcSEcCtD
Paclitaxel—Shock—Epirubicin—hematologic cancer	3.64e-06	2.43e-05	CcSEcCtD
Paclitaxel—Convulsion—Doxorubicin—hematologic cancer	3.64e-06	2.43e-05	CcSEcCtD
Paclitaxel—Nervous system disorder—Epirubicin—hematologic cancer	3.63e-06	2.42e-05	CcSEcCtD
Paclitaxel—Thrombocytopenia—Epirubicin—hematologic cancer	3.63e-06	2.42e-05	CcSEcCtD
Paclitaxel—Hypertension—Doxorubicin—hematologic cancer	3.63e-06	2.42e-05	CcSEcCtD
Paclitaxel—Tachycardia—Epirubicin—hematologic cancer	3.62e-06	2.41e-05	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Methotrexate—hematologic cancer	3.61e-06	2.41e-05	CcSEcCtD
Paclitaxel—Skin disorder—Epirubicin—hematologic cancer	3.6e-06	2.4e-05	CcSEcCtD
Paclitaxel—Dizziness—Dexamethasone—hematologic cancer	3.6e-06	2.4e-05	CcSEcCtD
Paclitaxel—Dizziness—Betamethasone—hematologic cancer	3.6e-06	2.4e-05	CcSEcCtD
Paclitaxel—Hyperhidrosis—Epirubicin—hematologic cancer	3.58e-06	2.39e-05	CcSEcCtD
Paclitaxel—Insomnia—Methotrexate—hematologic cancer	3.58e-06	2.39e-05	CcSEcCtD
Paclitaxel—Chest pain—Doxorubicin—hematologic cancer	3.58e-06	2.39e-05	CcSEcCtD
Paclitaxel—Arthralgia—Doxorubicin—hematologic cancer	3.58e-06	2.39e-05	CcSEcCtD
Paclitaxel—Myalgia—Doxorubicin—hematologic cancer	3.58e-06	2.39e-05	CcSEcCtD
Paclitaxel—Anxiety—Doxorubicin—hematologic cancer	3.56e-06	2.38e-05	CcSEcCtD
Paclitaxel—Nausea—Triamcinolone—hematologic cancer	3.56e-06	2.38e-05	CcSEcCtD
Paclitaxel—Paraesthesia—Methotrexate—hematologic cancer	3.55e-06	2.37e-05	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	3.55e-06	2.37e-05	CcSEcCtD
Paclitaxel—Discomfort—Doxorubicin—hematologic cancer	3.53e-06	2.36e-05	CcSEcCtD
Paclitaxel—Anorexia—Epirubicin—hematologic cancer	3.53e-06	2.36e-05	CcSEcCtD
Paclitaxel—Dyspnoea—Methotrexate—hematologic cancer	3.53e-06	2.35e-05	CcSEcCtD
Paclitaxel—Somnolence—Methotrexate—hematologic cancer	3.52e-06	2.35e-05	CcSEcCtD
Paclitaxel—Dry mouth—Doxorubicin—hematologic cancer	3.5e-06	2.33e-05	CcSEcCtD
Paclitaxel—Hypersensitivity—Prednisone—hematologic cancer	3.49e-06	2.33e-05	CcSEcCtD
Paclitaxel—Dyspepsia—Methotrexate—hematologic cancer	3.48e-06	2.33e-05	CcSEcCtD
Paclitaxel—Hypotension—Epirubicin—hematologic cancer	3.46e-06	2.31e-05	CcSEcCtD
Paclitaxel—Vomiting—Dexamethasone—hematologic cancer	3.46e-06	2.31e-05	CcSEcCtD
Paclitaxel—Vomiting—Betamethasone—hematologic cancer	3.46e-06	2.31e-05	CcSEcCtD
Paclitaxel—Confusional state—Doxorubicin—hematologic cancer	3.46e-06	2.31e-05	CcSEcCtD
Paclitaxel—Decreased appetite—Methotrexate—hematologic cancer	3.44e-06	2.3e-05	CcSEcCtD
Paclitaxel—Rash—Betamethasone—hematologic cancer	3.43e-06	2.29e-05	CcSEcCtD
Paclitaxel—Rash—Dexamethasone—hematologic cancer	3.43e-06	2.29e-05	CcSEcCtD
Paclitaxel—Anaphylactic shock—Doxorubicin—hematologic cancer	3.43e-06	2.29e-05	CcSEcCtD
Paclitaxel—Oedema—Doxorubicin—hematologic cancer	3.43e-06	2.29e-05	CcSEcCtD
Paclitaxel—Dermatitis—Dexamethasone—hematologic cancer	3.43e-06	2.29e-05	CcSEcCtD
Paclitaxel—Dermatitis—Betamethasone—hematologic cancer	3.43e-06	2.29e-05	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.42e-06	2.28e-05	CcSEcCtD
Paclitaxel—Fatigue—Methotrexate—hematologic cancer	3.41e-06	2.28e-05	CcSEcCtD
Paclitaxel—Headache—Dexamethasone—hematologic cancer	3.41e-06	2.27e-05	CcSEcCtD
Paclitaxel—Headache—Betamethasone—hematologic cancer	3.41e-06	2.27e-05	CcSEcCtD
Paclitaxel—Infection—Doxorubicin—hematologic cancer	3.41e-06	2.27e-05	CcSEcCtD
Paclitaxel—Asthenia—Prednisone—hematologic cancer	3.4e-06	2.27e-05	CcSEcCtD
Paclitaxel—Pain—Methotrexate—hematologic cancer	3.39e-06	2.26e-05	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Epirubicin—hematologic cancer	3.38e-06	2.25e-05	CcSEcCtD
Paclitaxel—Shock—Doxorubicin—hematologic cancer	3.37e-06	2.25e-05	CcSEcCtD
Paclitaxel—Nervous system disorder—Doxorubicin—hematologic cancer	3.36e-06	2.24e-05	CcSEcCtD
Paclitaxel—Thrombocytopenia—Doxorubicin—hematologic cancer	3.36e-06	2.24e-05	CcSEcCtD
Paclitaxel—Pruritus—Prednisone—hematologic cancer	3.35e-06	2.24e-05	CcSEcCtD
Paclitaxel—Insomnia—Epirubicin—hematologic cancer	3.35e-06	2.24e-05	CcSEcCtD
Paclitaxel—Tachycardia—Doxorubicin—hematologic cancer	3.35e-06	2.23e-05	CcSEcCtD
Paclitaxel—Skin disorder—Doxorubicin—hematologic cancer	3.33e-06	2.22e-05	CcSEcCtD
Paclitaxel—Paraesthesia—Epirubicin—hematologic cancer	3.33e-06	2.22e-05	CcSEcCtD
Paclitaxel—Hyperhidrosis—Doxorubicin—hematologic cancer	3.31e-06	2.21e-05	CcSEcCtD
Paclitaxel—Dyspnoea—Epirubicin—hematologic cancer	3.3e-06	2.2e-05	CcSEcCtD
Paclitaxel—Somnolence—Epirubicin—hematologic cancer	3.29e-06	2.2e-05	CcSEcCtD
Paclitaxel—Anorexia—Doxorubicin—hematologic cancer	3.27e-06	2.18e-05	CcSEcCtD
Paclitaxel—Feeling abnormal—Methotrexate—hematologic cancer	3.26e-06	2.18e-05	CcSEcCtD
Paclitaxel—Dyspepsia—Epirubicin—hematologic cancer	3.26e-06	2.18e-05	CcSEcCtD
Paclitaxel—Diarrhoea—Prednisone—hematologic cancer	3.24e-06	2.16e-05	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Methotrexate—hematologic cancer	3.24e-06	2.16e-05	CcSEcCtD
Paclitaxel—Nausea—Betamethasone—hematologic cancer	3.23e-06	2.16e-05	CcSEcCtD
Paclitaxel—Nausea—Dexamethasone—hematologic cancer	3.23e-06	2.16e-05	CcSEcCtD
Paclitaxel—Decreased appetite—Epirubicin—hematologic cancer	3.22e-06	2.15e-05	CcSEcCtD
Paclitaxel—Hypotension—Doxorubicin—hematologic cancer	3.2e-06	2.14e-05	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.2e-06	2.13e-05	CcSEcCtD
Paclitaxel—Fatigue—Epirubicin—hematologic cancer	3.19e-06	2.13e-05	CcSEcCtD
Paclitaxel—Constipation—Epirubicin—hematologic cancer	3.17e-06	2.11e-05	CcSEcCtD
Paclitaxel—Pain—Epirubicin—hematologic cancer	3.17e-06	2.11e-05	CcSEcCtD
Paclitaxel—Urticaria—Methotrexate—hematologic cancer	3.14e-06	2.1e-05	CcSEcCtD
Paclitaxel—Dizziness—Prednisone—hematologic cancer	3.13e-06	2.09e-05	CcSEcCtD
Paclitaxel—Abdominal pain—Methotrexate—hematologic cancer	3.13e-06	2.09e-05	CcSEcCtD
Paclitaxel—Body temperature increased—Methotrexate—hematologic cancer	3.13e-06	2.09e-05	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3.12e-06	2.08e-05	CcSEcCtD
Paclitaxel—Insomnia—Doxorubicin—hematologic cancer	3.1e-06	2.07e-05	CcSEcCtD
Paclitaxel—Paraesthesia—Doxorubicin—hematologic cancer	3.08e-06	2.05e-05	CcSEcCtD
Paclitaxel—Dyspnoea—Doxorubicin—hematologic cancer	3.06e-06	2.04e-05	CcSEcCtD
Paclitaxel—Feeling abnormal—Epirubicin—hematologic cancer	3.05e-06	2.04e-05	CcSEcCtD
Paclitaxel—Somnolence—Doxorubicin—hematologic cancer	3.05e-06	2.03e-05	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Epirubicin—hematologic cancer	3.03e-06	2.02e-05	CcSEcCtD
Paclitaxel—Dyspepsia—Doxorubicin—hematologic cancer	3.02e-06	2.01e-05	CcSEcCtD
Paclitaxel—Vomiting—Prednisone—hematologic cancer	3.01e-06	2.01e-05	CcSEcCtD
Paclitaxel—Rash—Prednisone—hematologic cancer	2.99e-06	1.99e-05	CcSEcCtD
Paclitaxel—Dermatitis—Prednisone—hematologic cancer	2.98e-06	1.99e-05	CcSEcCtD
Paclitaxel—Decreased appetite—Doxorubicin—hematologic cancer	2.98e-06	1.99e-05	CcSEcCtD
Paclitaxel—Headache—Prednisone—hematologic cancer	2.97e-06	1.98e-05	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.96e-06	1.97e-05	CcSEcCtD
Paclitaxel—Fatigue—Doxorubicin—hematologic cancer	2.96e-06	1.97e-05	CcSEcCtD
Paclitaxel—Urticaria—Epirubicin—hematologic cancer	2.94e-06	1.96e-05	CcSEcCtD
Paclitaxel—Pain—Doxorubicin—hematologic cancer	2.93e-06	1.96e-05	CcSEcCtD
Paclitaxel—Constipation—Doxorubicin—hematologic cancer	2.93e-06	1.96e-05	CcSEcCtD
Paclitaxel—Body temperature increased—Epirubicin—hematologic cancer	2.93e-06	1.95e-05	CcSEcCtD
Paclitaxel—Abdominal pain—Epirubicin—hematologic cancer	2.93e-06	1.95e-05	CcSEcCtD
Paclitaxel—Hypersensitivity—Methotrexate—hematologic cancer	2.92e-06	1.95e-05	CcSEcCtD
Paclitaxel—Asthenia—Methotrexate—hematologic cancer	2.84e-06	1.9e-05	CcSEcCtD
Paclitaxel—Feeling abnormal—Doxorubicin—hematologic cancer	2.82e-06	1.88e-05	CcSEcCtD
Paclitaxel—Nausea—Prednisone—hematologic cancer	2.81e-06	1.88e-05	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.8e-06	1.87e-05	CcSEcCtD
Paclitaxel—Pruritus—Methotrexate—hematologic cancer	2.8e-06	1.87e-05	CcSEcCtD
Paclitaxel—Hypersensitivity—Epirubicin—hematologic cancer	2.73e-06	1.82e-05	CcSEcCtD
Paclitaxel—Urticaria—Doxorubicin—hematologic cancer	2.72e-06	1.82e-05	CcSEcCtD
Paclitaxel—Body temperature increased—Doxorubicin—hematologic cancer	2.71e-06	1.81e-05	CcSEcCtD
Paclitaxel—Abdominal pain—Doxorubicin—hematologic cancer	2.71e-06	1.81e-05	CcSEcCtD
Paclitaxel—Diarrhoea—Methotrexate—hematologic cancer	2.71e-06	1.81e-05	CcSEcCtD
Paclitaxel—Asthenia—Epirubicin—hematologic cancer	2.66e-06	1.77e-05	CcSEcCtD
Paclitaxel—Pruritus—Epirubicin—hematologic cancer	2.62e-06	1.75e-05	CcSEcCtD
Paclitaxel—Dizziness—Methotrexate—hematologic cancer	2.62e-06	1.75e-05	CcSEcCtD
Paclitaxel—Diarrhoea—Epirubicin—hematologic cancer	2.53e-06	1.69e-05	CcSEcCtD
Paclitaxel—Hypersensitivity—Doxorubicin—hematologic cancer	2.53e-06	1.69e-05	CcSEcCtD
Paclitaxel—Vomiting—Methotrexate—hematologic cancer	2.52e-06	1.68e-05	CcSEcCtD
Paclitaxel—Rash—Methotrexate—hematologic cancer	2.5e-06	1.67e-05	CcSEcCtD
Paclitaxel—Dermatitis—Methotrexate—hematologic cancer	2.49e-06	1.66e-05	CcSEcCtD
Paclitaxel—Headache—Methotrexate—hematologic cancer	2.48e-06	1.65e-05	CcSEcCtD
Paclitaxel—Asthenia—Doxorubicin—hematologic cancer	2.46e-06	1.64e-05	CcSEcCtD
Paclitaxel—Dizziness—Epirubicin—hematologic cancer	2.45e-06	1.63e-05	CcSEcCtD
Paclitaxel—Pruritus—Doxorubicin—hematologic cancer	2.43e-06	1.62e-05	CcSEcCtD
Paclitaxel—Vomiting—Epirubicin—hematologic cancer	2.36e-06	1.57e-05	CcSEcCtD
Paclitaxel—Nausea—Methotrexate—hematologic cancer	2.35e-06	1.57e-05	CcSEcCtD
Paclitaxel—Diarrhoea—Doxorubicin—hematologic cancer	2.35e-06	1.56e-05	CcSEcCtD
Paclitaxel—Rash—Epirubicin—hematologic cancer	2.34e-06	1.56e-05	CcSEcCtD
Paclitaxel—Dermatitis—Epirubicin—hematologic cancer	2.33e-06	1.56e-05	CcSEcCtD
Paclitaxel—Headache—Epirubicin—hematologic cancer	2.32e-06	1.55e-05	CcSEcCtD
Paclitaxel—Dizziness—Doxorubicin—hematologic cancer	2.27e-06	1.51e-05	CcSEcCtD
Paclitaxel—Nausea—Epirubicin—hematologic cancer	2.2e-06	1.47e-05	CcSEcCtD
Paclitaxel—Vomiting—Doxorubicin—hematologic cancer	2.18e-06	1.45e-05	CcSEcCtD
Paclitaxel—Rash—Doxorubicin—hematologic cancer	2.16e-06	1.44e-05	CcSEcCtD
Paclitaxel—Dermatitis—Doxorubicin—hematologic cancer	2.16e-06	1.44e-05	CcSEcCtD
Paclitaxel—Headache—Doxorubicin—hematologic cancer	2.15e-06	1.43e-05	CcSEcCtD
Paclitaxel—Nausea—Doxorubicin—hematologic cancer	2.04e-06	1.36e-05	CcSEcCtD
Paclitaxel—ABCB11—Metabolism—PIK3R1—hematologic cancer	1.04e-06	1.27e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ADCY7—hematologic cancer	1.03e-06	1.25e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—NCOA3—hematologic cancer	1.03e-06	1.25e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PIK3CB—hematologic cancer	1.02e-06	1.24e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ALOX5—hematologic cancer	1.02e-06	1.24e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—NUP214—hematologic cancer	1.02e-06	1.24e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.02e-06	1.24e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.01e-06	1.22e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—MTR—hematologic cancer	1e-06	1.21e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ABCG2—hematologic cancer	1e-06	1.21e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MAP2K1—hematologic cancer	9.99e-07	1.21e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	9.96e-07	1.21e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PIK3CD—hematologic cancer	9.93e-07	1.21e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	9.92e-07	1.2e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—KRAS—hematologic cancer	9.91e-07	1.2e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CYCS—hematologic cancer	9.91e-07	1.2e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—MTHFR—hematologic cancer	9.9e-07	1.2e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—NUP98—hematologic cancer	9.89e-07	1.2e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	9.85e-07	1.2e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—MTHFR—hematologic cancer	9.82e-07	1.19e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ENO2—hematologic cancer	9.81e-07	1.19e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PIK3CB—hematologic cancer	9.64e-07	1.17e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	9.62e-07	1.17e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ADCY7—hematologic cancer	9.6e-07	1.17e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—NCOA3—hematologic cancer	9.6e-07	1.17e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	9.59e-07	1.17e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—FHL2—hematologic cancer	9.56e-07	1.16e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—NUP214—hematologic cancer	9.53e-07	1.16e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GSTT1—hematologic cancer	9.51e-07	1.16e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—FGF2—hematologic cancer	9.5e-07	1.15e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3CG—hematologic cancer	9.5e-07	1.15e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3CG—hematologic cancer	9.46e-07	1.15e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	9.44e-07	1.15e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—AGRN—hematologic cancer	9.38e-07	1.14e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PIK3R1—hematologic cancer	9.37e-07	1.14e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—MTR—hematologic cancer	9.34e-07	1.13e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ABCG2—hematologic cancer	9.34e-07	1.13e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—SDC1—hematologic cancer	9.3e-07	1.13e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	9.23e-07	1.12e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ENO2—hematologic cancer	9.16e-07	1.11e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3CG—hematologic cancer	9.15e-07	1.11e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—JAK2—hematologic cancer	9.11e-07	1.11e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—PIK3CA—hematologic cancer	9.11e-07	1.11e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—NQO1—hematologic cancer	9.07e-07	1.1e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CD44—hematologic cancer	9.07e-07	1.1e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	8.9e-07	1.08e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MDM2—hematologic cancer	8.89e-07	1.08e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—HMMR—hematologic cancer	8.89e-07	1.08e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—IDH2—hematologic cancer	8.89e-07	1.08e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GSTT1—hematologic cancer	8.88e-07	1.08e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	8.88e-07	1.08e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PTEN—hematologic cancer	8.86e-07	1.08e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—CREBBP—hematologic cancer	8.8e-07	1.07e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—CREBBP—hematologic cancer	8.77e-07	1.06e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	8.75e-07	1.06e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GSTP1—hematologic cancer	8.74e-07	1.06e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—SDC1—hematologic cancer	8.68e-07	1.05e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MTOR—hematologic cancer	8.65e-07	1.05e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PIK3CB—hematologic cancer	8.65e-07	1.05e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CD4—hematologic cancer	8.64e-07	1.05e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CYCS—hematologic cancer	8.58e-07	1.04e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	8.53e-07	1.04e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—CREBBP—hematologic cancer	8.48e-07	1.03e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—EP300—hematologic cancer	8.44e-07	1.03e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—HRAS—hematologic cancer	8.43e-07	1.02e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ARNTL—hematologic cancer	8.36e-07	1.02e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3CD—hematologic cancer	8.35e-07	1.01e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	8.33e-07	1.01e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PTEN—hematologic cancer	8.33e-07	1.01e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CG—hematologic cancer	8.32e-07	1.01e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3CD—hematologic cancer	8.31e-07	1.01e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	8.3e-07	1.01e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ABCB1—hematologic cancer	8.27e-07	1e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CG—hematologic cancer	8.25e-07	1e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—ALB—hematologic cancer	8.24e-07	1e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—ALB—hematologic cancer	8.21e-07	9.97e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	8.19e-07	9.95e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ACP5—hematologic cancer	8.13e-07	9.87e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CA9—hematologic cancer	8.13e-07	9.87e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CDKN1B—hematologic cancer	8.12e-07	9.86e-06	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IL6—hematologic cancer	8.06e-07	9.8e-06	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3CD—hematologic cancer	8.04e-07	9.77e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—NCOR1—hematologic cancer	8.03e-07	9.75e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GSTM1—hematologic cancer	8.03e-07	9.75e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—NCOR2—hematologic cancer	8.02e-07	9.75e-06	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—EP300—hematologic cancer	7.95e-07	9.65e-06	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—ALB—hematologic cancer	7.94e-07	9.64e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—NQO1—hematologic cancer	7.9e-07	9.6e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CD44—hematologic cancer	7.9e-07	9.6e-06	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3R1—hematologic cancer	7.88e-07	9.58e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3R1—hematologic cancer	7.85e-07	9.53e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	7.83e-07	9.52e-06	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CREBBP—hematologic cancer	7.71e-07	9.37e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	7.68e-07	9.33e-06	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CREBBP—hematologic cancer	7.65e-07	9.29e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—IDH1—hematologic cancer	7.64e-07	9.28e-06	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3R1—hematologic cancer	7.59e-07	9.22e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GSTP1—hematologic cancer	7.57e-07	9.19e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTO1—hematologic cancer	7.56e-07	9.18e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—TXN—hematologic cancer	7.56e-07	9.18e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ABCC3—hematologic cancer	7.56e-07	9.18e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CDKN1A—hematologic cancer	7.49e-07	9.1e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CYCS—hematologic cancer	7.48e-07	9.09e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PTEN—hematologic cancer	7.48e-07	9.08e-06	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—AKT1—hematologic cancer	7.44e-07	9.04e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—HSP90AA1—hematologic cancer	7.43e-07	9.03e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SPHK1—hematologic cancer	7.4e-07	8.98e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CD44—hematologic cancer	7.38e-07	8.97e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—NQO1—hematologic cancer	7.38e-07	8.97e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	7.32e-07	8.89e-06	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CD—hematologic cancer	7.31e-07	8.89e-06	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3CB—hematologic cancer	7.28e-07	8.84e-06	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CD—hematologic cancer	7.25e-07	8.81e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3CB—hematologic cancer	7.25e-07	8.8e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	7.23e-07	8.78e-06	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—ALB—hematologic cancer	7.22e-07	8.77e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ABCB1—hematologic cancer	7.16e-07	8.7e-06	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—ALB—hematologic cancer	7.16e-07	8.69e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—EP300—hematologic cancer	7.13e-07	8.66e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—UGT1A1—hematologic cancer	7.11e-07	8.63e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—MTHFR—hematologic cancer	7.1e-07	8.62e-06	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3CB—hematologic cancer	7.01e-07	8.51e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYCS—hematologic cancer	6.99e-07	8.49e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GSTM1—hematologic cancer	6.95e-07	8.45e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—NCOR1—hematologic cancer	6.95e-07	8.45e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	6.94e-07	8.43e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—SRC—hematologic cancer	6.93e-07	8.42e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SLC22A1—hematologic cancer	6.91e-07	8.4e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CRABP1—hematologic cancer	6.91e-07	8.4e-06	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3R1—hematologic cancer	6.91e-07	8.39e-06	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3R1—hematologic cancer	6.85e-07	8.32e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ALOX5—hematologic cancer	6.74e-07	8.18e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—STAT3—hematologic cancer	6.69e-07	8.12e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—NRAS—hematologic cancer	6.67e-07	8.1e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GSTP1—hematologic cancer	6.59e-07	8.01e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—NUP98—hematologic cancer	6.52e-07	7.92e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MAPK3—hematologic cancer	6.39e-07	7.76e-06	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CB—hematologic cancer	6.38e-07	7.74e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ADCY7—hematologic cancer	6.33e-07	7.69e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—NCOA3—hematologic cancer	6.33e-07	7.69e-06	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CB—hematologic cancer	6.32e-07	7.68e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—NUP214—hematologic cancer	6.29e-07	7.64e-06	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PTEN—hematologic cancer	6.29e-07	7.64e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PTEN—hematologic cancer	6.26e-07	7.61e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.25e-07	7.59e-06	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PIK3CA—hematologic cancer	6.25e-07	7.59e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MYC—hematologic cancer	6.21e-07	7.55e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—TGFB1—hematologic cancer	6.2e-07	7.53e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—MTR—hematologic cancer	6.16e-07	7.48e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ABCG2—hematologic cancer	6.16e-07	7.48e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GSTP1—hematologic cancer	6.16e-07	7.48e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—MTHFR—hematologic cancer	6.15e-07	7.47e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—NCOR1—hematologic cancer	6.06e-07	7.36e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GSTM1—hematologic cancer	6.06e-07	7.36e-06	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PTEN—hematologic cancer	6.06e-07	7.36e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ENO2—hematologic cancer	6.04e-07	7.34e-06	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—EP300—hematologic cancer	6e-07	7.28e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—EP300—hematologic cancer	5.97e-07	7.25e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CG—hematologic cancer	5.96e-07	7.24e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.96e-07	7.24e-06	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PIK3CA—hematologic cancer	5.88e-07	7.14e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTT1—hematologic cancer	5.86e-07	7.12e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ABCB1—hematologic cancer	5.83e-07	7.08e-06	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—EP300—hematologic cancer	5.77e-07	7.01e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—KRAS—hematologic cancer	5.74e-07	6.97e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SDC1—hematologic cancer	5.73e-07	6.96e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GSTM1—hematologic cancer	5.66e-07	6.87e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—NCOR1—hematologic cancer	5.66e-07	6.87e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CREBBP—hematologic cancer	5.53e-07	6.71e-06	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PTEN—hematologic cancer	5.51e-07	6.69e-06	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PTEN—hematologic cancer	5.46e-07	6.63e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.42e-07	6.58e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—MTHFR—hematologic cancer	5.35e-07	6.5e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PIK3CA—hematologic cancer	5.27e-07	6.41e-06	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—EP300—hematologic cancer	5.25e-07	6.38e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CD—hematologic cancer	5.24e-07	6.37e-06	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—EP300—hematologic cancer	5.21e-07	6.33e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ALB—hematologic cancer	5.17e-07	6.28e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CG—hematologic cancer	5.16e-07	6.27e-06	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—AKT1—hematologic cancer	5.1e-07	6.2e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—MTHFR—hematologic cancer	5e-07	6.08e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3R1—hematologic cancer	4.95e-07	6.01e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—HRAS—hematologic cancer	4.88e-07	5.93e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CD44—hematologic cancer	4.87e-07	5.92e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—NQO1—hematologic cancer	4.87e-07	5.92e-06	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—AKT1—hematologic cancer	4.8e-07	5.83e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CREBBP—hematologic cancer	4.79e-07	5.82e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—IL6—hematologic cancer	4.67e-07	5.67e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYCS—hematologic cancer	4.61e-07	5.6e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	4.58e-07	5.56e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CB—hematologic cancer	4.57e-07	5.55e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CD—hematologic cancer	4.54e-07	5.51e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CG—hematologic cancer	4.5e-07	5.46e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ALB—hematologic cancer	4.48e-07	5.44e-06	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3CA—hematologic cancer	4.44e-07	5.39e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3CA—hematologic cancer	4.42e-07	5.37e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.41e-07	5.35e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—AKT1—hematologic cancer	4.31e-07	5.23e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3R1—hematologic cancer	4.29e-07	5.21e-06	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3CA—hematologic cancer	4.27e-07	5.19e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CG—hematologic cancer	4.2e-07	5.1e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CREBBP—hematologic cancer	4.17e-07	5.07e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTP1—hematologic cancer	4.06e-07	4.93e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CB—hematologic cancer	3.96e-07	4.81e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CD—hematologic cancer	3.95e-07	4.8e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PTEN—hematologic cancer	3.95e-07	4.79e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ALB—hematologic cancer	3.9e-07	4.74e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CREBBP—hematologic cancer	3.9e-07	4.73e-06	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CA—hematologic cancer	3.89e-07	4.72e-06	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CA—hematologic cancer	3.85e-07	4.68e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ABCB1—hematologic cancer	3.84e-07	4.67e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—EP300—hematologic cancer	3.76e-07	4.57e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3R1—hematologic cancer	3.73e-07	4.54e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—NCOR1—hematologic cancer	3.73e-07	4.53e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTM1—hematologic cancer	3.73e-07	4.53e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CD—hematologic cancer	3.69e-07	4.49e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ALB—hematologic cancer	3.65e-07	4.43e-06	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—AKT1—hematologic cancer	3.62e-07	4.4e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—AKT1—hematologic cancer	3.61e-07	4.38e-06	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—AKT1—hematologic cancer	3.49e-07	4.24e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3R1—hematologic cancer	3.49e-07	4.24e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CB—hematologic cancer	3.45e-07	4.19e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PTEN—hematologic cancer	3.42e-07	4.15e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—MTHFR—hematologic cancer	3.3e-07	4.01e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—EP300—hematologic cancer	3.26e-07	3.96e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CB—hematologic cancer	3.22e-07	3.91e-06	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—AKT1—hematologic cancer	3.17e-07	3.86e-06	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—AKT1—hematologic cancer	3.15e-07	3.82e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PTEN—hematologic cancer	2.98e-07	3.62e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—EP300—hematologic cancer	2.84e-07	3.45e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CA—hematologic cancer	2.78e-07	3.38e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PTEN—hematologic cancer	2.78e-07	3.38e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.77e-07	3.37e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—EP300—hematologic cancer	2.65e-07	3.22e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.57e-07	3.12e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.44e-07	2.96e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CA—hematologic cancer	2.41e-07	2.93e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ALB—hematologic cancer	2.41e-07	2.92e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.3e-07	2.79e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—AKT1—hematologic cancer	2.27e-07	2.76e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.12e-07	2.58e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CA—hematologic cancer	2.1e-07	2.55e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—AKT1—hematologic cancer	1.97e-07	2.39e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.96e-07	2.38e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PTEN—hematologic cancer	1.84e-07	2.23e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—EP300—hematologic cancer	1.75e-07	2.13e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—AKT1—hematologic cancer	1.72e-07	2.09e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—AKT1—hematologic cancer	1.6e-07	1.95e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.29e-07	1.57e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—AKT1—hematologic cancer	1.06e-07	1.28e-06	CbGpPWpGaD
